Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism

J. I. Weitz*, A. W. A. Lensing, M. H. Prins, R. Bauersachs, J. Beyer-Westendorf, H. Bounameaux, T. A. Brighton, A. T. Cohen, B. L. Davidson, H. Decousus, M. C. S. Freitas, G. Holberg, A. K. Kakkar, L. Haskell, B. van Bellen, A. F. Pap, S. D. Berkowitz, P. Verhamme, P. S. Wells, P. PrandoniEINSTEIN CHOICE Investigators

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1211-1222
Number of pages12
JournalNew England Journal of Medicine
Volume376
Issue number13
DOIs
Publication statusPublished - 30 Mar 2017

Keywords

  • INTENSITY WARFARIN THERAPY
  • TOTAL KNEE ARTHROPLASTY
  • LONG-TERM
  • NONSURGICAL PATIENTS
  • ATRIAL-FIBRILLATION
  • HIP-ARTHROPLASTY
  • PREVENTION
  • ENOXAPARIN
  • THROMBOPROPHYLAXIS
  • THROMBOSIS

Cite this

Weitz, J. I., Lensing, A. W. A., Prins, M. H., Bauersachs, R., Beyer-Westendorf, J., Bounameaux, H., Brighton, T. A., Cohen, A. T., Davidson, B. L., Decousus, H., Freitas, M. C. S., Holberg, G., Kakkar, A. K., Haskell, L., van Bellen, B., Pap, A. F., Berkowitz, S. D., Verhamme, P., Wells, P. S., ... EINSTEIN CHOICE Investigators (2017). Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism. New England Journal of Medicine, 376(13), 1211-1222. https://doi.org/10.1056/NEJMoa1700518